---
title: "Goldman Sachs Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280003577.md"
description: "In a report released yesterday, from Goldman Sachs maintained a Buy rating on Giant Biogene Holding Co. Ltd., with a price target of HK$46.00.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Giant Biogene Holding Co. Ltd. has an analyst consensus of Strong Buy, with a price target consensus of HK$48.53."
datetime: "2026-03-21T00:35:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280003577.md)
  - [en](https://longbridge.com/en/news/280003577.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280003577.md)
---

# Goldman Sachs Reaffirms Their Buy Rating on Giant Biogene Holding Co. Ltd. (2367)

In a report released yesterday, from Goldman Sachs maintained a Buy rating on Giant Biogene Holding Co. Ltd., with a price target of HK$46.00.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Giant Biogene Holding Co. Ltd. has an analyst consensus of Strong Buy, with a price target consensus of HK$48.53.

### Related Stocks

- [02367.HK](https://longbridge.com/en/quote/02367.HK.md)

## Related News & Research

- [Giant Biogene Sets 2026 AGM to Refresh Board Mandates and Appoint New Auditor](https://longbridge.com/en/news/285394236.md)
- [Citic Securities Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)](https://longbridge.com/en/news/283910584.md)
- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [Goldman Sachs Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)](https://longbridge.com/en/news/286522682.md)
- [Morgan Stanley Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)](https://longbridge.com/en/news/270232349.md)